BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30536464)

  • 61. Metastatic sympathetic paraganglioma in a patient with loss of the SDHC gene.
    Rich T; Jackson M; Roman-Gonzalez A; Shah K; Cote GJ; Jimenez C
    Fam Cancer; 2015 Dec; 14(4):615-9. PubMed ID: 26162468
    [TBL] [Abstract][Full Text] [Related]  

  • 62. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.
    Bayley JP; Kunst HP; Cascon A; Sampietro ML; Gaal J; Korpershoek E; Hinojar-Gutierrez A; Timmers HJ; Hoefsloot LH; Hermsen MA; Suárez C; Hussain AK; Vriends AH; Hes FJ; Jansen JC; Tops CM; Corssmit EP; de Knijff P; Lenders JW; Cremers CW; Devilee P; Dinjens WN; de Krijger RR; Robledo M
    Lancet Oncol; 2010 Apr; 11(4):366-72. PubMed ID: 20071235
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Disease monitoring of patients with pheochromocytoma or paraganglioma by biomarkers and imaging studies.
    Schreiner F; Beuschlein F
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101347. PubMed ID: 31662271
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
    Baysal BE; Maher ER
    Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Models of parent-of-origin tumorigenesis in hereditary paraganglioma.
    Hoekstra AS; Devilee P; Bayley JP
    Semin Cell Dev Biol; 2015 Jul; 43():117-124. PubMed ID: 26067997
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
    Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
    Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and/or Paraganglioma.
    Yonamine M; Wasano K; Aita Y; Sugasawa T; Takahashi K; Kawakami Y; Shimano H; Nishiyama H; Hara H; Naruse M; Okamoto T; Matsuda T; Kosugi S; Horiguchi K; Tanabe A; Watanabe A; Kimura N; Nakamura E; Sakurai A; Shiga K; Takekoshi K
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439168
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Pheochromocytoma and paraganglioma].
    Gimenez-Roqueplo AP
    Rev Prat; 2015 Jun; 65(6):826-30. PubMed ID: 26298909
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Hereditary pheochromocytoma and paraganglioma].
    Musil Z; Vícha A; Zelinka T; Turková H; Labudová T; Kohoutová M; Pacák K
    Klin Onkol; 2012; 25 Suppl():S21-6. PubMed ID: 22920202
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Whole Exome Sequencing Identifies Novel Genetic Alterations in Patients with Pheochromocytoma/Paraganglioma.
    Seo SH; Kim JH; Kim MJ; Cho SI; Kim SJ; Kang H; Shin CS; Park SS; Lee KE; Seong MW
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):909-917. PubMed ID: 33397043
    [TBL] [Abstract][Full Text] [Related]  

  • 71. When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma?
    Erlic Z; Neumann HP
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):354-7. PubMed ID: 19067729
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Silent genetic alterations identified by targeted next-generation sequencing in pheochromocytoma/paraganglioma: A clinicopathological correlations.
    Pillai S; Gopalan V; Lo CY; Liew V; Smith RA; Lam AK
    Exp Mol Pathol; 2017 Feb; 102(1):41-46. PubMed ID: 27986441
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel Germline
    Provenzano A; Chetta M; De Filpo G; Cantini G; La Barbera A; Nesi G; Santi R; Martinelli S; Rapizzi E; Luconi M; Maggi M; Mannelli M; Ercolino T; Canu L
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013579
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recurrent Disease in Patients With Sporadic Pheochromocytoma and Paraganglioma.
    Li M; Prodanov T; Meuter L; Kerstens MN; Bechmann N; Prejbisz A; Remde H; Timmers HJLM; Nölting S; Talvacchio S; Berends AMA; Fliedner S; Robledo M; Lenders JWM; Pacak K; Eisenhofer G; Pamporaki C
    J Clin Endocrinol Metab; 2023 Jan; 108(2):397-404. PubMed ID: 36190922
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.
    Rusyn L; Kohn B
    Pediatr Endocrinol Rev; 2017 Mar; 14(3):312-325. PubMed ID: 28508602
    [No Abstract]   [Full Text] [Related]  

  • 76. Should genetic testing be performed in each patient with sporadic pheochromocytoma at presentation?
    Pigny P; Cardot-Bauters C; Do Cao C; Vantyghem MC; Carnaille B; Pattou F; Caron P; Wemeau JL; Porchet N
    Eur J Endocrinol; 2009 Feb; 160(2):227-31. PubMed ID: 19029228
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma.
    Burnichon N; Vescovo L; Amar L; Libé R; de Reynies A; Venisse A; Jouanno E; Laurendeau I; Parfait B; Bertherat J; Plouin PF; Jeunemaitre X; Favier J; Gimenez-Roqueplo AP
    Hum Mol Genet; 2011 Oct; 20(20):3974-85. PubMed ID: 21784903
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
    Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
    J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
    [TBL] [Abstract][Full Text] [Related]  

  • 79. From Nf1 to Sdhb knockout: Successes and failures in the quest for animal models of pheochromocytoma.
    Lepoutre-Lussey C; Thibault C; Buffet A; Morin A; Badoual C; Bénit P; Rustin P; Ottolenghi C; Janin M; Castro-Vega LJ; Trapman J; Gimenez-Roqueplo AP; Favier J
    Mol Cell Endocrinol; 2016 Feb; 421():40-8. PubMed ID: 26123588
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genetic testing in pheochromocytoma: increasing importance for clinical decision making.
    Bornstein SR; Gimenez-Roqueplo AP
    Ann N Y Acad Sci; 2006 Aug; 1073():94-103. PubMed ID: 17102076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.